Acta Scientific Clinical Case Reports

Editorial Volume 1 Issue 6

Seizures in the Current COVID Pandemic: An Editorial

Arun Swaminathan*

Assistant Professor of Neurology/Epilepsy, Medical Student CST Phase 3 Director, Member, Interprofessional Academy of Educators, University of Nebraska Medical Center, Omaha, Nebraska, USA

*Corresponding Author: Arun Swaminathan, Assistant Professor of Neurology/ Epilepsy, Medical Student CST Phase 3 Director, Member, Interprofessional Academy of Educators, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Received: May 29, 2020; Published: June 02, 2020


 The current COVID pandemic has been a life altering and history- changing event worldwide and has had massive repercussions in patient life and medical sciences. The WHO estimates that millions of people have been affected by the pandemic and deaths will eventually range in the hundreds of thousands and potentially exceed a million. While respiratory failure is the overwhelming concern in these COVID patients, medical providers have noted that many comorbidities have complicated medical care and worsened outcomes in these patients. Seizures and epilepsy represent common comorbidities in these patients due to their high burden in the general population and special attention has been paid to their interactions with the COVID pandemic.



  1. Bohmwald K., et al. “Neurologic Alterations Due to Respiratory Virus Infections”. Frontiers in Cellular Neuroscience 12 (2018): 386.
  2. Suen WW., et al. “Mechanism of west nile virus neuroinvasion: a critical appraisal”. Viruses7 (2014): 2796-2825.
  3. Swanson PA and McGavern DB. “Chapter 2. Portals of viral entry into the central nervous system”. In the Blood-Brain Barrier in Health and Disease, ed. Dorovini-Zis K. (Boca Raton, FL: CRC Press) (2015): 23-47.
  4. Swanson PA and, McGavern DB. “Viral diseases of the central nervous system”. Current Opinion in Virology 11 (2015): 44-54.
  5. Bergmann CC., et al. “Coronavirus infection of the central nervous system: host-virus stand-off”. Nature Reviews Microbiology 2 (2006): 121-132.
  6. Hung Ec., et al. “Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome”. Clinical Chemistry 12 (2003): 2108-2109.
  7. Asadi-Pooya Ali A. “Seizures associated with coronavirus infections”. Seizure 79 (2020): 49-52.
  8. Farrokh S., et al. “Antiepileptic drugs in critically ill patients”. Critical Care 1 (2018): 153.
  9. Lachuer C., et al. “Complete Atrioventricular Block in an Elderly Patient Treated with Low-Dose Lacosamide”. Cardiovascular Toxicology 6 (2018): 579-582.
  10. Lai SL., et al. “The impact of SARS on epilepsy: the experience of drug withdrawal in epileptic patients”. Seizure 8 (2005): 557-561.
  11. Haddad N., et al. “Telemedicine for patients with epilepsy: a pilot experience”. Epilepsy and Behavior 44 (2015): 1-4.


Citation: Arun Swaminathan. “Seizures in the Current COVID Pandemic: An Editorial”. Acta Scientific Clinical Case Reports 1.6 (2020): 01-02.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.278

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US